Laddar...
High-risk Stage II Colorectal Cancers Carry an Equivalent Risk of Peritoneal Recurrence to Stage III
Background/Aim: Several risk factors for recurrence have been identified in stage II colorectal cancer. However, in contrast to stage III, the benefits of adjuvant chemotherapy for these patients remain controversial. We hypothesized that the different impacts of chemotherapy may be due to different...
Sparad:
| I publikationen: | In Vivo |
|---|---|
| Huvudupphovsmän: | , , , , , , , , , |
| Materialtyp: | Artigo |
| Språk: | Inglês |
| Publicerad: |
International Institute of Anticancer Research
2018
|
| Ämnen: | |
| Länkar: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6199616/ https://ncbi.nlm.nih.gov/pubmed/30150450 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.21873/invivo.11370 |
| Taggar: |
Lägg till en tagg
Inga taggar, Lägg till första taggen!
|